Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association [PDF]
Thrombosis JournalBackground Lupus anticoagulant (LA) is an in vitro phenomenon with prolongation of a phospholipid-dependent coagulation test which is not due to an inhibitor specific to a coagulation factor.
Ting Hon Stanford Li +4 more
doaj +2 more sources
Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report [PDF]
Journal of Medical Case Reports, 2022 Background Acquired hemophilia A is a disorder caused by autoantibodies against coagulation factor VIII that may present with severe bleeding. We report a rare case of acquired hemophilia A presenting with coexisting lupus anticoagulant.
Victor Chen +4 more
doaj +2 more sources
Journal of Marine Medical SocietyBackground: Antiphospholipid antibodies (aPL), a heterogeneous group of circulating antibodies including lupus anticoagulant (LAC), anticardiolipin antibodies (aCL), & anti-beta-2-glycoprotein 1 antibodies (aβ2GP1) that have been associated with ...
Blessy Mathew +5 more
doaj +2 more sources
Current Controversies in Lupus Anticoagulant Detection
Antibodies, 2016 Antiphospholipid syndrome is an autoimmune, acquired thrombophilia diagnosed when vascular thrombosis or pregnancy morbidity are accompanied by persistent antiphospholipid antibodies.
Gary W. Moore
doaj +2 more sources
A Case of Acute Coalescent Mastoiditis With Early Diagnosis of Lupus Anticoagulant-Hypoprothrombinemia Syndrome Prompting Immediate Surgical Drainage. [PDF]
CureusSaito Y, Hasegawa M, Araki K.
europepmc +3 more sources
Patient with lupus anticoagulant caused aPTT prolongation corrected with prednisolone treatment and later anticoagulation treatment due to chronic atrial fibrillation. [PDF]
Clin Case Rep, 2023 Frydrysiak M +3 more
europepmc +3 more sources
Lupus anticoagulant in patients with COVID-19: A review [PDF]
Journal of Preventive Epidemiology, 2021 Introduction: Coronavirus disease 2019 (COVID-19) is characterized by a pro-coagulant state that can lead to fatal thromboembolic events. A high prevalence of lupus anticoagulant has been shown in several studies that may at least partially explain the ...
Milad Nazari Sabet +2 more
doaj +1 more source
Revista Cubana de Hematología, Inmunología y Hemoterapia, 2005 Se realizó un estudio retrospectivo de los resultados de la determinación del anticoagulante lúpico (AL) realizadas en el período comprendido entre julio del 2000 y julio del 2004 en el laboratorio de hemostasis del Instituto de Hematología e Inmunología.
Alina Díaz Concepción +2 more
doaj +1 more source
Performance characteristics of 5 numerical indexes in mixing test interpretation under coexistence of lupus anticoagulant and coagulation factor deficiency. [PDF]
Res Pract Thromb Haemost, 2023 Matsuda M +5 more
europepmc +3 more sources